IMPROVE-IT

Principal Investigator:
John F. Collins, MD (St. Marys)
William Felten, MD (Covenant)

Sub Investigators:
Umesh Badami, MD                    Alok Maheshwari, MD
Peter Fattal, MD                          Rao Gudipati, MD
Safwan Kassas, MD                     Daniel Lee, MD
Stephen Mattichak, MD                Gregory Pellizzon, MD
Shiraz Shariff, MD                       Manoj Sharma, MD
Kondaramvalappil Ravindrin, MD

Sponsor:
Schering-Plough Research

Study:
A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs. Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial - IMPROVE IT)

Objective:
The intent of this clinical study is to demonstrate such benefit of Ezetimibe/Simvastatin Combination over at least 4-5 years of follow up in high risk coronary artery disease subjects beyond known benefits of Simvastatin Monotherapy.

Status:
Active enrollment

If you have any questions, please feel free to contact the coordinators, and they will be happy to answer any questions you have regarding this study.

<< Back